The Narcotics Control Bureau (NCB) has said clandestine laboratories manufacturing mephedrone are turning to commonly available hydrobromic acid to get around restrictions on a key precursor chemical. On March 11, the Union finance ministry's revenue department notified 2-Bromo-4-Methylpropiophenone as the eighth chemical on the controlled substance list, acting after the NCB alerted the home and finance ministries that the compound was being used in illicit labs to prepare mephedrone.
According to the NCB, the control on the supply and sale of the compound was meant to check such labs, but recent busts show an alternative route being adopted. On November 15, the NCB and Gujarat Police busted a mephedrone laboratory in Ahmedabad's Sarkhej, concealed in the basement of a residential building with its entrance hidden behind what appeared to be a wardrobe and a removable section of tiled flooring. The agency said it recovered 25 chemicals weighing 130.613 kg, including methylamine, bromine and hydrobromic acid, along with equipment used in manufacturing the drug, and suspected mephedrone in powder and liquid form.
The NCB said the Ahmedabad case indicated that traffickers were attempting to circumvent the control by using an alternative manufacturing method. An NCB officer, who asked not to be named, said a person accused of preparing the drug in Rajasthan told them hydrobromic acid was needed only to start a specific reaction, and that the end product remained the same. In the Ahmedabad case, the accused, Mudasar Ahmed Khan, told investigators he learnt the process through the internet and was attempting to produce good-quality drugs after procuring chemicals and equipment from Mandsaur and Ahmedabad, and online. Investigators also found he ran a café suspected to have been used as a delivery point for mephedrone, and that four criminal cases had previously been registered against him.
The NCB called for continuous intelligence development, close monitoring of precursor supply chains and rapid information sharing among enforcement agencies, regulators and industry. It urged chemical and pharmaceutical manufacturers, importers, distributors and traders to implement its Voluntary Code of Conduct for Preventing Diversion of Precursor Chemicals, including effective KYC, verification of the purchaser's business and declared end use, and complete and auditable transaction records. The agency said vigilance must cover notified controlled substances as well as non-scheduled precursor and pre-precursor chemicals that may be diverted for manufacturing synthetic drugs.
